FORT LAUDERDALE, Fla., May 1, 2013 /PRNewswire/ -- Scientists have linked chronic inflammatory events in the brain with the onset and progression of Alzheimer's disease. Now, South Florida residents who have mild or moderate Alzheimer's disease can participate in a study that measures the effects of a novel medication therapy to reduce inflammation and a nutritional supplement program.
(Logo: http://photos.prnewswire.com/prnh/20120223/FL58611LOGO-b )
The Life Extension Foundation® is seeking five study participants who will receive blood tests, health evaluations, blood pressure checks, dietary supplements and study medication at no cost as well as compensation up to $500 for study participation. The study runs approximately 29 weeks.
Life Extension Foundation is a non-profit 501(c)(3) organization dedicated to finding new scientific methods to enhance and expand the healthy human life span. It funds research programs aimed at developing new anti-aging therapies and combating such age-related killers as heart disease, stroke, cancer, and Alzheimer's disease. Life Extension Foundation has donated over $100 million to anti-aging and disease prevention studies.
Alzheimer's disease, the most common form of dementia affecting people aged 65 years and older, is characterized by memory impairment and changes in behavior, emotion, and personality. Initial symptoms are short-term memory lapses that worsen until patients cannot recognize their own family members. As dementia progresses, hostile emotional outbursts often manifest, and individuals lose the ability to take care of themselves. There are FDA approved medications that may temporarily improve symptoms but current medical treatments for Alzheimer's disease do not prevent long-term clinical deterioration.
For study information call toll-free at 866-517-4536 or email [email protected]. Study pre-registration is available at www.LEF.org/ClinicalResearch.
For more information: |
Sheldon Baker |
Life Extension |
|
954.790.5512 cell |
SOURCE Life Extension Foundation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article